A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)

NCT05494593 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study was closed due to enrollment challenges

Conditions

Mucopolysaccharidosis (MPS)
Hunter Syndrome

Interventions

DRUG: ELAPRASE
DRUG: Rituximab
DRUG: Methotrexate
DRUG: Intravenous Immunoglobulin (IVIG)

Sponsor

Takeda

Collaborators

[object Object]